verapamil has been researched along with thioacetamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hafez, HM; Hassan, M; Hassanein, H; Ibrahim, MA; Zedan, MZ | 1 |
| Hafez, HM; Hassan, M; Ibrahim, MA; Mohamed, MZ | 1 |
2 other study(ies) available for verapamil and thioacetamide
| Article | Year |
|---|---|
Nephroprotective effect of cilostazol and verapamil against thioacetamide-induced toxicity in rats may involve Nrf2/HO-1/NQO-1 signaling pathway.
Topics: Animals; Antioxidants; Cilostazol; Cytoprotection; Disease Models, Animal; Heme Oxygenase (Decyclizing); Kidney; Kidney Diseases; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Thioacetamide; Verapamil | 2019 |
PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Heme Oxygenase (Decyclizing); Liver; Male; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Thioacetamide; Verapamil | 2019 |